Use of a non-specific immunomodulation therapy as a therapeutic vasculogenesis strategy in no-option critical limb ischemia patients.

Source:http://linkedlifedata.com/resource/pubmed/id/19709658

Download in:

View as

Triples

General Info

PMID
19709658